540例患者中药注射剂临床用药治疗的合理性分析

Analysis of Clinical Medication Rationality in 540 Patients by Using Traditional Chinese Medicine Injection

目的:分析中药注射剂临床用药治疗的合理性及其不合理原因。方法:抽取2015年1月—2016年6月间使用中药注射剂治疗患者,每月随机抽取30例,共540例,分析临床使用合理性以及不合理的原因。结果:在抽取的540份病历中,不合理使用的共有125份,其中适应证不合理的为2例,混合配伍不合理的为8例,溶媒选择不合理的为37例,使用频次不合理的为11例,疗程不合理的为3例,使用剂量不合理的为60例,其他不合理情况的为4例;不合理使用的主要药品有艾迪、丹参多酚、丹参、喜炎平、血必净等,基本涵盖了临床使用量较多的抗癌、活血化淤、抗感染等几大类药物。结论:中药注射剂临床使用尚待规范,临床药师仍需加强干预,保证患者用药的安全性和合理性。

Objective： To analyze the clinical medication rationality and unreasonable use in 540 patients by using traditional chinese medicine injections. Methods： We collect 540 cases （30 cases per month） who used traditional Chinese medicine injection and also hospitalized in our hospital between January 2015 and June 2016. This paper analyzes the rea- son of unreasonable use in clinical. Results： There are 125 unreasonable uses in cases, indications unreasonable in 2 cas- es, hybrid compatibility unreasonable in 8 cases, solvent selection unreasonable in 37 cases, use frequency unreasonable in 11 cases, treatment unreasonable in 3 cases, the dose unreasonable in 60 cases and 4 cases of other unreasonable condi- tions. The main medicines of Unreasonable use are Aidi injection, Salvia Miltiorrhiza injection, salvianolate injection, Xi- yanping injection, Xuebijing injection etc., basically covering cancer drugs clinical usage, drugs stimulating circulation to end stasis, anti-infection drugs and after broad categories. Conclusion： Traditional Chinese medicine injection in clinical use is not yet to be standardized, clinical pharmacists still tionality of drug use. need to strengthen the intervention, ensure patient safety and ra-